Sikar doc, pharmacist suspended; new guidelines for syrup issued

Jaipur:  The health department on Thursday suspended a govt doctor and a pharmacist of Sikar district for allegedly prescribing a cough syrup containing dextromethorphan to children, a drug which cannot be prescribed to those under four years. This follows the deaths of two children who allegedly died in Sikar and Bharatpur districts after taking ‘Dextromethorphan HBr Syrup’.In its Thursday edition, TOI had in a report — ‘State govt failed to heed previous cough syrup warnings, say activists’ — highlighted the death of children allegedly after taking the syrup in Delhi in 2021, and how the state govt had failed to learn from the incident.

Acting on the news report, the health department on Thursday issued fresh guidelines for prescribing the cough syrup and suspended a doctor and a pharmacist for allegedly prescribing the medicine to children. The department’s director of public health, Dr Ravi Prakash Sharma, said action has been taken to suspend Dr Palak and pharmacist Pappu Soni for prescribing the syrup to a child at Hathideh PHC in Ajitgarh block of Sikar.Along with necessary action in the case, the department also issued an advisory on following protocol of providing medicines to patients only with prescriptions.It also advised patients against taking medicines without medical consultation, and called for complete compliance of doctors with the advisory.

The department also clarified that some children who had consumed the syrup had survived. A 30-year-old patient Monu Joshi, a resident of Kalsada, Bharatpur, had come to CHC on Sept 25, with cough, cold, and fever on Sept 25. The doctor had prescribed the syrup to him along with other medicines. When his three-year-old son Gagan caught cold and pneumonia, Joshi gave the syrup to the child without a doctor’s advice.The child’s condition worsened and he was taken to a doctor in Mahua, who referred him to JK Lon, Jaipur. His condition improved and he was discharged on Sept 27.

Related Posts

Rajasthan Bans 7 Sub-Standard Medicines

Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality”. Prioritising…

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

Rajasthan Bans 7 Sub-Standard Medicines

Rajasthan Bans 7 Sub-Standard Medicines

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23